Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

This study has been completed.
Information provided by:
International Extranodal Lymphoma Study Group (IELSG) Identifier:
First received: September 13, 2005
Last updated: March 27, 2015
Last verified: March 2015